Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia

Published:2010-10-14 Issue:1 Volume:25 Page:181-184
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Handgretinger R,Zugmaier G,Henze G,Kreyenberg H,Lang P,von Stackelberg A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010239.pdf

Reference8 articles.

1. Loren AW, Porter DL . Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Bone Marrow Transplant 2008; 41: 483–493.

2. Klingebiel T, Lang P, Schumm M, Koehl U, Bader P, Schwabe D et al. Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. Pathol Biol (Paris) 2005; 53: 159–161.

3. Bader P, Kreyenberg H, Henze GH, Eckert C, Reising M, Willasch A et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. J Clin Oncol 2009; 27: 377–384.

4. Jeha S . New therapeutic strategies in acute lymphoblastic leukemia. Semin Hematol 2009; 46: 76–88.

5. Baeuerle PA, Kufer P, Bargou R . BiTE: teaching antibodies to engage T-cells for cancer therapy. Curr Opin Mol Ther 2009; 11: 22–30.

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products;The Journal of Clinical Pharmacology;2024-08-16

2. Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report;Clinical Pediatric Hematology-Oncology;2024-04-30

3. Acute Lymphoblastic Leukaemia in Children and Adolescents;The EBMT Handbook;2024

4. Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation;International Journal of Molecular Sciences;2023-11-09

5. Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond;Cancers;2023-06-26